D E Meyers W F Hill A Suo V Jimenez-Zepeda T Cheng N A Nixon
10.1186/s40164-018-0098-5
Exp Hematol Oncol
2018 Mar 20;7:6.
adverse events ctla-4 immune checkpoint blockade immunotherapy melanoma pd-1
CC BY
https://pubmed.ncbi.nlm.nih.gov/29568696/
Case Reports
PMC5859826
29568696
Aplastic anemia secondary to nivolumab and ipilimumab in a patient with metastatic melanoma: a case report
2018